Detection of mutations in insulin receptor gene by denaturing gradient gel electrophoresis. 1992

F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892.

Denaturing gradient gel electrophoresis (DGGE) has been used to screen for mutations in the insulin receptor gene. Each of the 22 exons was amplified by the polymerase chain reaction (PCR). For each exon, one of the two PCR primers contained a guanine-cytosine (GC) clamp at its 5' end. The DNA was analyzed by electrophoresis through a polyacrylamide gel containing a gradient of denaturants. Two geometries for the gels were compared; the gradient of denaturants was oriented either parallel or perpendicular to the electric field. The sensitivity of the technique was evaluated by determining whether DGGE succeeded in detecting known mutations and polymorphisms in the insulin receptor gene. With parallel gels, 12 of 16 sequence variants were detected. The use of perpendicular gels increased the sensitivity of detection so that all 16 sequence variants were successfully detected when DNA was analyzed by a combination of perpendicular and parallel gels. Furthermore, DGGE was used to investigate a patient with leprechaunism whose insulin receptor genes had not previously been studied. Two mutant alleles were identified in this patient. The allele inherited from the father had a mutation substituting alanine for Val-28; in the allele inherited from the mother, arginine was substituted for Gly-366.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009691 Nucleic Acid Denaturation Disruption of the secondary structure of nucleic acids by heat, extreme pH or chemical treatment. Double strand DNA is "melted" by dissociation of the non-covalent hydrogen bonds and hydrophobic interactions. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible. DNA Denaturation,DNA Melting,RNA Denaturation,Acid Denaturation, Nucleic,Denaturation, DNA,Denaturation, Nucleic Acid,Denaturation, RNA,Nucleic Acid Denaturations
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females

Related Publications

F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
May 2001, Current protocols in human genetics,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
January 1993, Human mutation,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
December 1997, Electrophoresis,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
January 1994, Human mutation,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
December 1998, Clinical chemistry and laboratory medicine,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
January 1994, Methods in enzymology,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
March 1998, Nucleic acids research,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
January 1999, Methods in molecular medicine,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
January 1994, Human mutation,
F Barbetti, and P V Gejman, and S I Taylor, and N Raben, and A Cama, and E Bonora, and P Pizzo, and P Moghetti, and M Muggeo, and J Roth
January 1993, Molecular carcinogenesis,
Copied contents to your clipboard!